[HTML][HTML] CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
The emerging central role of CD36 in cellular lipid homeostasis and recently obtained
molecular insight in the interplay among metabolic substrates indicate the applicability of
CD36 as target for metabolic modulation therapy in disease. Experimental studies already
have shown the feasibility of this approach.
molecular insight in the interplay among metabolic substrates indicate the applicability of
CD36 as target for metabolic modulation therapy in disease. Experimental studies already
have shown the feasibility of this approach.
Summary
The emerging central role of CD36 in cellular lipid homeostasis and recently obtained molecular insight in the interplay among metabolic substrates indicate the applicability of CD36 as target for metabolic modulation therapy in disease. Experimental studies already have shown the feasibility of this approach.
Lippincott Williams & Wilkins